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Methotrexate (MTX) is an anti-folate drug that is widely used in the treatment of 
rheumatic disorders and malignant tumors. The efficacy of MTX is often limited by 
its severe side effects and toxic sequelae. Propolis (bee glue) is a natural bee product 
rich in polyphenolic compounds known for antioxidant activity. The present study 
was designed to evaluate the protective role of propolis (PP) extract against oxidative 
stress induced by methotrexate drug (MTX) on liver and brain of rats. The nutritive 
value and some main active polyphenolic compounds and antioxidant capacity of the 
propolis extract were evaluated. The total phenolic and flavonoid contents of propolis 
extract recorded in terms of mg gallic acid and catechin equivalent/100 ml extract 
were 1122.4 mg and 2885 mg respectively. In addition highly total antioxidant 
capacity presented as 178 mg ascorbic acid equivalent. Gas chromatography mass 
spectrometry (GC-MS) was performed for qualitative screening of phenolic 
compounds in the propolis. One hundred and twenty male Wistar albino rats with 
mean body weights 90 g ± 5 g were classified into 5 groups. Rats were administered 
their respective doses of propolis extract and/or MTX for 3, 6 and 9 weeks intervals. 
Control groups (G1 and G2), propolis extract group (G3), MTX group (G4) and MTX 
plus propolis extract group (G5). Results suggested that co-administration of the PP 
extract with MTX reduced the deleterious effects of methotrexate, through the 
significant increase in concentration of reduced glutathione (GSH) and inhibition of 
lipid peroxidation as observed by significant decrease in malondialdehyde (MDA) 
level in brain tissue. As well as, significant increase in antioxidant enzyme activities 
(superoxide dismutase (SOD), glutathione peroxidase (GPx), and glutathione 
reductase (GR)) in liver and brain tissues as compared to MTX group alone at p<0.05 
in a time dependent manner to approach the values found in control rats. Data showed 
that propolis has a powerful antioxidant capacity. It is capable of modulating the 
antioxidant enzyme activities and suppressing the oxidative damage induced by MTX 
drug in liver and brain tissues. 
Propolis administration for 9 weeks proved to have remarkable protective effect 





MTX is one of the earliest cytotoxic chemotherapeutic agent to treat various neoplastic diseases such as acute 
lymphoblastic leukemia, lymphoma, solid cancers. It is also one of the commonly used medications in the treatment 
of rheumatoid arthritis. It has the potential to generate free radicals, and such free radicals could precipitate 
oxidative stress especially in the presence of insufficient endogenous antioxidant enzymes within the biological 
system (Mohamed and Metwally, 2009). MTX is used in chemotherapy regimen in which it does not discriminate 
between normal and malignant cells and hence promotes even normal cells toward apoptosis (Ali et al., 2014). 
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Long-term drug administration can cause accumulation of MTX polyglutamates and decreased folate levels. The 
presence of higher levels of polyglutamates causes a longer intracellular presence of the drug and this has been 
suggested as a mechanism for MTX hepatotoxicity (Jahovic et al., 2003). The depletion of nucleic acid precursors 
seems to be responsible for the cytostatic and cytotoxic effects of methotrexate (Neradil et al., 2012 and Rathaur, 
2013).   
 
Methotrexate drug-induced oxidative stress is implicated as a mechanism of toxicity in numerous tissues and organ 
systems, including liver, kidney, cardiovascular and nervous systems. Metabolism of a drug may generate ROS, 
perturbations in oxidant homeostasis and mitochondrial dysfunction which contribute to clinically relevant drug side 
effects (Deavall etal., 2012). The drug could decrease the availability of NADPH in cells. This was the main reason 
for significant reduction in reduced glutathione level promoted by MTX and could lead to the reduction of 
antioxidant enzyme defense system effectiveness (Vardi et al., 2010). 
 
In addition, deficits in neurological and cognitive function are complication of therapy that can persist in the years 
following treatment. MTX exerts anti-neoplastic effects by inhibiting folate-dependent thymidine and purine 
synthesis. This disruption of folate homeostasis within the nervous system may also explain its neurotoxic effects 
via inhibition of critical physiological processes, toxic substance accumulation and direct neuronal damage (Li et al., 
2010). 
 
There are many reasons which make nervous system organs susceptible to oxidative damage include; high oxygen 
uptake, neuronal membrane lipids rich in polyunsaturated fatty acids, modest antioxidant defense and several auto-
oxidizable neurotransmitters (Bhalla and Dhawan, 2009). Brain is sensitive to lipid peroxidation-mediated injury 
because of its unique abundance of membrane lipids. ROS generation may cause abnormal cellular function, disrupt 
cell membrane integrity, increase blood brain barrier permeability and initiate apoptotic and necrotic cell death 
pathways  (Gadoth and Göbel, 2011).  
 
Supplementation with natural anti-oxidants may reduce the toxic effect of anticancer drugs. It dose not only prevent 
free radicals from causing damage but repair any damages. Propolis is recently a most important dietary supplement 
as antioxidant compound, providing protection against free radicals adverse effects. Realizing this fact, propolis was 
taken into account as a natural product for emerging its protective efficacy (Lushchak, 2012). Propolis has attracted 
much attention in recent years as a useful substance for medicines and cosmetics, although it has been used in folk 
medicine since ancient times (Wagh, 2013).  
  
Polyphenols (including flavonoids, phenolic acids and their esters) are considered to be the main pharmacologically 
active molecules in propolis. They inhibit lipid peroxidation, platelet aggregation, capillary permeability and 
fragility and the activity of enzymes including cyclooxygenase and lipoxygenase as well as simulate some hormones 
(Tatli-Seven et al., 2009). Propolis is rich of essential elements, including Zn+2, Mg+2, Cu+2, Fe+2, Mn+2, Ni+2 and 
Ca+2, that might also be responsible for reactivating antioxidant enzymes by providing optimum trace 
elements(Farooqui and Farooqui, 2010).  
 
Materials and Methods 
1. Materials: 
Propolis (PP) was purchased from the faculty of agriculture, Cairo University, Giza, Egypt. Methotrexate drug 
(MTX) was imported from pharmaceutical company, Orion Corporation, Finland. Ethyl Alcohol (95 %) and 
dimethylsulphoxide (DMSO) of high analytical grade were supplied by El-Gomhoria Company for chemicals and 
drugs, Cairo, Egypt.  
2. Preparation of Propolis extract: 
Propolis extract was prepared by soaking 10 g in hydroalcoholic mixture (30% water and 70% ethanol) for three 
days in a dark place as described by Mani et al. (2006). After filtration, the extraction solvent was evaporated under 
vacuum using a rotary evaporator at 40°C and the solvent was removed. The viscous residue was obtained. 
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3. Nutritive value analysis of propolis: 
Protein, fat, carbohydrate and fiber content as well as ash and moisture, calcium, iron and sodium were measured 
according to (AOAC, 2000). 
4. Phytochemical and antioxidant analysis of propolis extract: 
Total phenolic content was determined by using Folin-Ciocalteau method according to Kumazawa et al. (2004). 
Aluminium chloride colorimetric method was used for determination of total flavonoids according to G´omez-
Caravaca et al. (2006). The stable 1,1-diphenyl-2-picryl hydrazyl (DPPH) radical was used for determination of free 
radical scavenging activity by spectrophotometric assay and represented as ascorbic acid equivalent as described by 
El-Sohaimy and Masry (2014). 
5. Gas chromatography-mass spectrometry (GC-MS) analysis of propolis: 
Gas chromatography mass spectrometry (GC-MS) was performed for qualitative screening of phenolic compounds 
in the propolis used in the study. Hewlett Packard 6890 series II gas chromatograph, an Agilent 5973 mass 
spectrometer with electron ionization was used. The GC was performed using a HP%-MS capillary column (30 m x 
0.25 mm, film thickness of 0.25 μm). Gas chromatography system equipped with mass detector was used for 
identification of compounds present in propolis sample.  GC sample injection (1µl) was performed in splitless mode. 
The GC oven temperature was programmed as follows: intial temperature 70ºC for 2min, 10ºC/ min up to 135ºC and 
4ºC/min up to 220ºC, 10ºC/ min up to 270ºC held for 4 min. Helium was used as carrier gas in constant flow mode 
at 1 ml/min. Relative percentage amounts of the separated compounds were calculated automatically from peak 
areas of the total ion chromatogram, using the Wiley 7 Nist05.L mass spectrometer data base to identify individual 
compounds. 
6. Animals and experimental design:    
In the present study one hundred and twenty male Wistar albino rats, weighting 90 5g were used. The animals were 
obtained from the animal house of Helwan-farm, Cairo, Egypt. After seven days of acclimatization, animals were 
housed individually in stainless-steel cages fitted with a wire mesh bottoms and fronts. The animals were randomly 
divided into five experimental groups of 24 rats (eight rats/weekly intervals, at 3, 6, and 9 consecutive weeks) and 
were provided with standard commercial diet according to NRC (1995) and water ad libitum. They maintained in an 
environmentally controlled animal house, temperature (25±5ºC) and relative humidity (50 ± 10) with 12 h light/dark 
cycle.   
 
Rats were weighed weekly, and then the oral dose of propolis extract was calculated and dissolved in 
dimethylsulphoxide (DMSO) immediately before use.  Propolis extract administered (Twice/week) at a dose of 200 
mg kg-1b.wt. (Çetin et al., 2011). The dose of propolis extract was given via intragastric intubation. Methotrexate 
(MTX) dose was calculated and dissolved in saline prior to use. It was intraperitoneally injected (Single dose/week) 
at a dose of 2.5 mg kg-1b.wt. (Rossato etal., 2014) The groups were divided as the following: 
Group 1 (control): Rats fed on standard commercial diet. 
Group 2 (saline+ DMSO): Rats fed on standard commercial diet+ administered DMSO (p.o.) and injected with 
saline (i.p.). 
Group 3 (PP group): Rats fed on standard commercial diet+ PP (p.o.). 
Group 4 (MTX group): Rats fed on standard commercial diet+ injected with MTX (i.p.) to induce stress in liver and 
brain. 
Group 5 (MTX+PP group): Rats fed on standard commercial diet+ administered PP extract (p.o.) and injected with 
MTX (i.p.). 
 
At weeks 3, 6 and 9 following initiation of the experiment, eight rats from each group were sacrificed after 12 hour 
fasting under anaethesia. Liver and brain were removed and washed twice with ice cold saline solution. Liver and 
brain tissues were stored at -20°C for estimation of various biochemical parameters. 
 
In the brain homogenate reduced glutathione was determined using the colorimetric method described by Beutler et 
al. (1963) using kits supplied by the Biodiagnostic Company, Giza, Egypt. Malondialdehyde was determined in the 
brain according to the colorimetric method described by Ohkawa et al. (1979) using Ben Italy kits. Glutathione 
reductase and glutathione peroxidase activities were determined in liver and brain homogenates according to the 
colorimetric method described by Goldberg and Spooner (1983) & Paglia and Valentine (1967) respectively using 
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kits supplied by the Biodiagnostic Company, Giza, Egypt. Superoxide dismutase activity was determined in liver 
and brain homogenates according to the colorimetric method described by Nishikimi et al. (1972) using Ben Italy 
kits. 
7. Statistical analysis: 
Statistical analyses were performed using the SPSS software (version 17; SPSS Inc., Chicago, IL, USA). The results 
were expressed as means ± standard deviation (SD). Differences between treatment groups were analyzed by least 
significant difference test (LSD) followed by Dunnett’s multiple comparisons test Levesque, (2007). The value of P 
< 0.05 was considered significant. 
 
Results 
The present study was conducted to investigate the possible cumulative damage produced by MTX on liver and 
brain over the duration of administration (3, 6 and 9 weeks) and the possible ameliorative effect of propolis in 
alleviating the MTX induced oxidative damage in rats. There were no major differences recorded between control 
groups (negative control group, (G1); Saline +DMSO group, (G2) and propolis group, (G3) at p<0.05).  
 
Chemical composition of propolis may vary substantially according to the origin of the samples and such differences 
are likely to affect its biological activities and consequently its clinical properties. Therefore, the assay of these 
components is of great importance. 
 
The obtained data gives an overview on nutritive value and some main active phytochemicals of the propolis extract 
used in the current study. Results of nutritive value analyses showed that each 100 g of propolis contains 4 g protein, 
2.11 g fat, 82.89 g carbohydrate, 10.5 g ash, 0.5g moisture, 1.98 mg iron, 15.93g calcium and 20.3 mg sodium. The 
values of total polyphenols measured in mg as gallic acid equivalent; GAE %, total flavonoids in mg as catechin 
equivalent; CE % and total antioxidant capacity as ascorbic acid content (mg %). Data showed that 100 ml of 
propolis extract contains 1122.4 mg GAE and 2885 mg CE. In addition highly total antioxidant capacity presented 
as 178 mg ascorbic acid equivalent. 
Gas chromatography mass spectrometry (GC-MS) was performed for qualitative screening of phenolic compounds 
in the propolis used in the study. Results showed that propolis sample contains caffeic acid phenethyl ester, chrysin, 
galangin, quercetin, kaempferol, pinocembrin and tectochrysin. The values presented in table (1) showed glutathione 
reductase, glutathione peroxidase and superoxide dismutase activities in liver tissue homogenate. It is clear that there 
were a statistically significant reduction in the activities of GR and GPx in the MTX group (G4) as compared to 
saline + DMSO group (G2). The activities of GR and GPx recorded decrease by -21.84%, -32.75% and -48.26% for 
GR and by -38.97%, -43.27% and -54.95% for GPx at 3, 6 and 9 weeks respectively as compared to control group 
(G2). The rats group consumed propolis extract with MTX drug (G5) showed significant increment in GR activity by 
5.71%, 25.91% and 81.27% and GPx activity by 27.61%, 46.88% and 102.99% in the three time intervals 
respectively compared to MTX group (G4).  
Also there was a great reduction in the activity of SOD in rats injected with MTX drug (G4) by -58.49%, -62.13% 
and -74.75% respectively compared to control group (G2). While there was a great increment in the activity of SOD 
in rats co-administered propolis extract with MTX drug at 3, 6 and 9 weeks by 15.90%, 51.28% and 173.07% 
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Table (1): Glutathione reductase (GR) (U/g), glutathione peroxidase (Gpx) (U/g) and superoxide dismutase 
(SOD) (mg/g) activities in liver tissue of the studied rat groups: 
 
GR, glutathione reductase; Gpx, glutathione peroxidase; SOD, superoxide dismutase. 
 Values are expressed as mean ± S.D, n=8 
 There was no significant difference between means have the same alphabetical superscripts (a, b, c) in the 
same row. 
 There was no significant difference between means have the same numerical value superscripts (1, 2, 3) in 
the same column. 
The results presented in tables (2&3) showed the effect of propolis and/or MTX treatment on glutathione reductase, 
glutathione peroxidase and superoxide dismutase activities and also, malondialdehyde (MDA) and reduced 
glutathione (GSH) concentration in brain tissue homogenate respectively. With respect to GR activity, it was 
significantly decreased in rats injected with MTX in the three time intervals as compared to saline + DMSO group 
(G2). After nine weeks GR activity was significantly decreased by -44.69% as compared to control group (G2). 
While propolis extract administration with MTX drug (G5) significantly increased GR activity after nine weeks by 
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Table (2): Glutathione reductase (GR) (U/g), glutathione peroxidase (Gpx) (U/g) and superoxide dismutase 
(SOD) (mg/g) activities in brain tissue of the studied rat groups: 
GR, glutathione reductase; Gpx, glutathione peroxidase; SOD, superoxide dismutase. 
 Values are expressed as mean ± S.D, n=8 
 There was no significant difference between means have the same alphabetical superscripts (a, b, c) in the 
same row. 
 There was no significant difference between means have the same numerical value superscripts (1, 2, 3) in 
the same column. 
Also there was a significant decrease in GPx activity after 3, 6 and 9 weeks in MTX injected rats (G4) as compared 
to control group (G2). GPx activity significantly decreased in MTX injected rats by -50.21% after nine weeks as 
compared to control group (G2) and significantly increased by 78.82% when propolis extract administered with 
MTX (G5) as compared to MTX group (G4). There was a significant reduction in SOD activity in MTX group by -
53.06%, -59.18% and -60.82% respectively when compared to control group (G2). When PP and MTX were 
administered simultaneously (G5), SOD activity increased by 8.69%, 30% and 63.15% respectively as compared to 
MTX group. 
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Table (3): GSH (mg/g tissue) and MDA (nmole/mg tissue) concentration in brain in the studied rats groups: 
 
MDA, malondialdehyde; GSH reduced glutathione.  
 Values are expressed as mean ± S.D, n=8 
 There was no significant difference between means have the same alphabetical superscripts (a, b, c) in the 
same row. 
 There was no significant difference between means have the same numerical value superscripts (1, 2, 3) in 
the same column. 
With respect to MDA concentration, results showed that when rats administered propolis extract with MTX drug 
(G5), marked reduction in the mean values of MDA concentration was observed in the three time intervals 10.97 ± 
0.44 nmole/mg vs. 14.93 ± 0.17 nmole/mg, 9.45 ± 0.25 nmole/mg vs.17.35 ± 0.15 nmole/mg and 7.72 ± 
0.65nmole/mg vs. 26.50 ± 1.32 nmole/mg respectively compared to MTX injected rats. Considering the results of 
GSH, values recorded in the control group (G2) were 74.70 ± 2.74 mg/g, 74.54 ± 1.69 mg/g and 73.70 ± 1.69 mg/g. 
From these values it is clear that MTX injected rats showed significant reduction in GSH to reach 55.82 ± 0.61 
mg/g, 52.50 ± 2.14 mg/g and 44.84 ± 2.76 mg/g respectively. In case of rats administered propolis extract with MTX 
drug there was a significant improvement in the values which were higher than those of MTX group which were 
60.22 ± 1.25 mg/g, 61.80 ± 2.73 mg/g and 67.27 ± 2.22 mg/g respectively. 
Discussion 
It was found that the total protein content in ethanolic extract of propolis by Kędzia (2009) is about 2.8 %. Among 
other components present in propolis there are micro- and macroelements. About 30 elements have been discovered 
in propolis by (Erenia and Tatiana, 2007), Calcium, manganese, zinc, copper and iron are present in the greatest 
amounts.  
 
Among the compounds identified in propolis according to (Kurek-Górecka et al., 2014) are: phenolic acids, 
flavonoids, terpenes, lipid-wax substances, beeswax, bio-elements and other components such as vitamins, proteins, 
amino acids and sugars. Phenolic compounds constitute the most numerous group of propolis components with 
respect to the quantity and type.  
 
The different flavonoids found in propolis by El-Masry etal., (2011) are: pinocembrin, acacetin, chrysin, rutin, 
catechin, naringenin, galangin, luteolin, kaemferol, apigenin, myricetin and quercetin, two phenolic acids, cinnamic 
and caffeic acid. Propolis contains acid derivatives such as benzoic-4- hydroxy benzoic which improves the 
digestive utilization of calcium (G´omez-Caravaca et al., 2006).  
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Ibrahim (2011) found that the total flavonoid and phenolic contents in alcoholic extract of propolis were 23.87 % 
and 31.25 % respectively. Also,  Abd El-Hady et al. (2013) found that the total phenolic and flavonoid contents of 
propolis extract recorded in terms of mg gallic acid equivalent/g and quercetin equivalent/g extract were 87.65 ± 0.5 
mg GAE/g and 113.14 ± 0.86 mg QE/g extract respectively.  
 
Results of Wided etal. (2014)  indicated that propolis extract contain high concentrations of phenolic compounds 
410.25 mg GAE/g and total flavonoid concentration is equal to 320.71 mg RE/g. Osman and Tantaway (2013) 
found that extract of propolis showed high phenol content was 157.99 ± 12.3 mg GAE/g. The total flavonoid content 
of propolis extract was 16.96 ± 1.48 mg/g. Moreover, results of Mateia et al. (2004) and Dobrinas et al. (2006) 
reported that ascorbic acid concentration in propolis sample was found to be 3.64 mg AA/g propolis. 
 
In the present study MTX caused significant progressive decrease in the activities of GR, GPx and SOD enzymes in 
liver cells over the duration of administration (3, 6 and 9 weeks). One of the sources of oxidative stress induced by 
some drugs is their metabolism, which generates ROS and reactive metabolites. This metabolism occurs mainly in 
the liver, but the metabolites may reach other tissues through the circulatory system. MTX causes aggressive cellular 
damage to the liver cells with destruction of their membranes and the release of the enzymes into the blood stream. 
 
These observations may be explained as; many chemotherapeutic drugs kill cancer cells oxidatively via the 
production of reactive oxygen species and the induction of either apoptosis or necrosis of tumorous cells; whereas 
others act on various components of cellular metabolism influencing activities of different enzymes needful for cell 
division. Since cytotoxicity not selective for cancer cells, it also affects normal cells (Sak, 2012).  
 
MTX is capable of generating potential toxic reactive oxygen species during its metabolism in the cell and thus the 
pro-oxidants-antioxidant balance that is usually maintained in a normal cell can be shifted towards the pro-oxidants 
following MTX metabolism Oguntibeju and Coleshowers, (2012) In addition, Rossato et al., (2013) reported that 
MTX and its toxic known metabolite accumulate in the liver tissue and its long-lasting effects can be attributed to 
MTX persistence in the cells and its strong affinity for cellular macromolecules and membranes.  
 
Results of Coleshowers et al. (2010) were matched with the results of this study, who reported that oxidative stress 
commences approximately after one week of MTX administration and increases progressively. Results showed that 
MTX caused a significant progressive decrease in SOD and GR activities in the liver at week (2, 3, 4, 5 and 6, 
respectively) as compared to the control group.  
 
Vardi et al. (2010) showed that MTX administration decreases the enzyme activities of SOD and GP-x capacity in 
liver. Furthermore, Abdel-Ghaffar et al., 2013 reported that, MTX treated rats exhibited a significant decrease in 
liver antioxidant machinery represented by  glutathione peroxidase, glutathione reductase and superoxide dismutase 
compared to control group. 
 
In the current study, the oral administration of propolis extract to MTX injected rats (G5) seems to significantly 
increased SOD, GR and GPx activities over the duration of administration time. The effect of propolis extract was 
more pronounced at 9 weeks. Propolis with its high concentration of flavonoids (polyphenolic compounds) 
possesses potent antioxidant and free radical scavenging activities.  Therefore, it is capable of modulating the 
antioxidant enzymes activities and suppressing the oxidative damage. Such improvement supports the hepato-
protective effects of propolis. This might be due to the accelerated regeneration of hepatic parenchymal cells under 
the influence of various bioactive compounds of propolis like flavonoids and their esters (Abu Aita et al., 2012 and 
EL-Mahalaway et al., 2015).  
 
Bhaduria, (2012) reviewed that propolis is  helpful in absorption and utilization of various minerals due to the 
presence of organic acid derivatives in it, which in turn improved physiological functions by regulating the ion 
dependent enzymatic activities. 
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The inhibition of ROS formation by propolis and its components provides a potential molecular basis for the 
protective actions of propolis through the retardation of NF-ĸB activation, inhibition of eicosanoid synthesis, and 
reduction in expression of various inflammatory cytokines in the nucleus, also through the inhibition of oxidative 
damage to proteins, lipids, DNA/RNA and carbohydrates (Farooqui and Farooqui, 2010 and El-Masry et al., 
2011). 
 
The present data is in consistent with that reported by Çetin et al. (2011) and Badr et al. (2011) they found that, co-
administration of propolis extract with MTX, significantly increased SOD, GPx activities. Study by Ali et al. (2014) 
demonstrated the protective effect of chrysin as a component of propolis against MTX-induced hepatotoxicity. 
Chrysin co-administration reversed the decrease in GPx, GR, SOD activities. 
 
It seems from the current study that, MTX injection significantly decreased the activities of GR, GPx and SOD and 
reduced GSH concentration in brain tissue. Oral administration of propolis reactivated the activities of GR, GPx and 
SOD and restored GSH concentration, and increased the detoxification of active metabolites of MTX. Also, MTX 
injection enhanced lipid peroxidation in brain tissue by increasing MDA concentration. While administration of 
propolis extract inhibited the generation of lipid peroxides that confirmed its anti-peroxidative effects against brain 
oxidative damage. The present findings demonstrate the neurotoxic effect of MTX.  
 
The decreased activities of these enzymes in MTX-treated group (G4) especially at 9 weeks indirectly showed an 
increase in ROS generation in brain cells. Confirm that long administration of MTX as long as 9 weeks may have 
adverse effects on antioxidant enzymes and cell integrity in the brain. Therefore cumulative effect of methotrexate 
could have played a role in this regard which could potentially lead to the release of more free radicals which 
interact with the cell membrane, causing membrane lysis and brain injury 
 
MTX is an analog of folic acid, exerts anti-neoplastic effects by inhibiting folate-dependent thymidine and purine 
synthesis. This disruption of folate homeostasis within the CNS may also explain its neurotoxic effects via inhibition 
of critical physiological processes, toxic substance accumulation, and direct neuronal damage. It may lead to CNS 
morphological and functional alterations, an imbalance in some neurotransmitters or inhibit neurogenesis due to 
ROS production. Furthermore, an inflammatory response, initiated by cells in response chemotherapy, also affect 
cognitive function and trigger secondary neuronal injury (Li et al., 2010). 
 
The present results are similar to that of Oguntibeju and Coleshowers, (2012) who found that MTX treatment 
caused a significant decrease in the activities of SOD and GR. In addition, Vardi et al. (2012) showed that MTX 
administration increases the level of MDA in the cerebellum and decreases the enzyme activity of SOD and GSH 
concentration. Also, Abdu, (2013) reported that MTX caused significant derease in the level of SOD and increase in 
MDA concentration in the cerebellum.  
 
The present data indicated that co-administration of propolis with MTX (G5) caused reduction in the MDA level and 
increased the activities of the antioxidant enzymes (SOD, GPx and GR) and increased the level of GSH in the brain. 
Mechanisms of antioxidant action may include suppression of ROS formation, removal or inactivation of oxygen 
reactive species and up-regulation or protection of antioxidant defenses (Montoro et al., 2005).  The results of 
Newairy and Abdou, (2013) reported that propolis was proved to be beneficial in decreasing the levels of free 
radicals and increasing the activities of the antioxidant enzymes. 
 
The biological effects exhibited by propolis could be related to an overall effect of the phenolic compounds present 
in propolis (El-Masry et al., 2011). It was reported that MTX caused significant decrease of SOD activity in spinal 
cord and brain stem tissues (Uzar et al., 2010) in comparison to control group. CAPE administration with MTX 
injection caused a significant decrease in MDA level and increase in SOD when compared with the MTX group. 
Kasai et al. (2011) reported that propolis and its constituents (CAPE, chrysin and pinocembrin) protect against 
neuronal death at least partly by the mediation of their anti-inflammatory and antioxidant activities. Pinocembrin, a 
flavonoid abundant in propolis had potent neuroprotective effects by improving mitochondrial function, decreasing 
oxidative damage, reducing neuronal apoptosis, and inhibiting inflammatory responses (Liu et al., 2012).  
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Propolis is a natural product and has a powerful antioxidant capacity. It is capable of modulating the antioxidant 
enzyme activities and suppressing the oxidative damage induced by MTX drug in liver and brain tissues. 
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